Grimes & Company’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.37M Sell
66,273
-896
-1% -$86.2K 0.13% 115
2026
Q2
$6.41M Buy
67,169
+3,048
+5% +$293K 0.14% 104
2026
Q1
$6.64M Buy
64,121
+24,577
+62% +$2.79M 0.18% 96
2025
Q4
$3.99M Sell
39,544
-26,924
-41% -$2.92M 0.1% 127
2025
Q3
$8.2M Sell
66,468
-2,411
-4% -$299K 0.2% 90
2025
Q2
$8.27M Buy
68,879
+9,615
+16% +$1.28M 0.23% 91
2025
Q1
$8.73M Buy
+59,264
New +$9.05M 0.27% 85

Other funds holding CLX

Grimes & Company's CLX Position: Q3 2026 in Review

Grimes & Company reduced its Clorox (CLX) stake by 1.3% in Q3 2026, selling an estimated $86.2K and leaving 66,273 shares worth $5.37M. The position accounts for 0.13% of the portfolio, ranked #115.

Grimes & Company first reported a position in CLX in Q1 2025 and has held it in 7 quarters since. The position peaked at $8.73M in Q1 2025. 843 funds tracked by Wall St. Rank hold CLX as of Q3 2026.

  • Grimes & Company held 66,273 shares of Clorox worth $5.37M as of Q3 2026.
  • Grimes & Company sold 896 Clorox shares in Q3 2026, an estimated $86.2K.
  • Clorox made up 0.13% of Grimes & Company's portfolio in Q3 2026, its #115 holding.
  • Grimes & Company first reported a position in Clorox in Q1 2025 and has held it in 7 quarters since.
  • Grimes & Company's Clorox position peaked at $8.73M in Q1 2025.
  • 843 funds tracked by Wall St. Rank held Clorox as of Q3 2026.

Based on Grimes & Company's 13F filing for Q3 2026, filed 29 Oct 2026.